Divisas / CDNA
CDNA: CareDx Inc
13.66
USD
0.55
(4.20%)
El tipo de cambio de CDNA de hoy ha cambiado un 4.20%. En este caso, el precio mínimo en el mercado ha alcanzado 13.06, mientras que el máximo ha alcanzado 13.76.
Siga la dinámica de la pareja de divisas CareDx Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CDNA News
- The Genomic Data Deluge: From Sequencing To Actionable Insights
- What's Going On With CareDx Stock Tuesday? - CareDx (NASDAQ:CDNA)
- William Blair initiates coverage on CareDx stock with Market Perform rating
- Do Options Traders Know Something About CareDx Stock We Don't?
- The Play On CareDx (NASDAQ:CDNA)
- CareDx stock price target lowered to $22 at BTIG on Medicare reimbursement concerns
- CareDx Q2 2025 slides: 14% revenue growth despite analyst miss, EBITDA surges
- CareDx secretary Novack sells $34,380 in shares
- Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings
- CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates
- AlloSure kidney transplant test shows strong predictive value for rejection
- CareDx launches AI-driven AlloSure Plus integrated with EPIC Aura
- CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
- Medicare draft policy continues coverage for transplant testing
- Abbott, Eli Lilly Lead Thursday’s Market Cap Stock Movers
- Oracle, Abbott lead Thursday’s market cap stock movers
- Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings - GameSquare Holdings (NASDAQ:GAME), CareDx (NASDAQ:CDNA)
- Caredx Inc stock hits 52-week low at 14.07 USD
- CareDx Q2 2024 presentation: Revenue jumps 31%, company raises full-year guidance
- Natera: Growth Likely To Moderate, Despite Signatera Test Medicare Coverage (NASDAQ:NTRA)
- CareDx Stock : Transplant Diagnostics Leader; Challenges Will Increase (CDNA)
- CareDx at Goldman Sachs Conference: Strategic Growth and Expansion
- Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
- CareDx at Jefferies Global Healthcare: Strategic Growth and Market Focus
Rango diario
13.06
13.76
Rango anual
10.96
32.97
- Cierres anteriores
- 13.11
- Open
- 13.17
- Bid
- 13.66
- Ask
- 13.96
- Low
- 13.06
- High
- 13.76
- Volumen
- 4.028 K
- Cambio diario
- 4.20%
- Cambio mensual
- 12.99%
- Cambio a 6 meses
- -37.60%
- Cambio anual
- -54.86%
31 agosto, domingo